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Abstract
 
Notch signaling is known to differentially affect the development of lymphoid B and T cell lin-
eages, but it remains unclear whether such effects are specifically dependent on distinct Notch
ligands. Using a cell coculture assay we observed that the Notch ligand Delta-1 completely in-
hibits the differentiation of human hematopoietic progenitors into the B cell lineage while pro-
moting the emergence of cells with a phenotype of T cell/natural killer (NK) precursors. In
contrast, Jagged-1 did not disturb either B or T cell/NK development. Furthermore, cells cul-
tured in the presence of either Delta-1 or Jagged-1 can acquire a phenotype of NK cells, and
Delta-1, but not Jagged-1, permits the emergence of a de novo cell population coexpressing
CD4 and CD8. Our results thus indicate that distinct Notch ligands can mediate differential ef-
fects of Notch signaling and provide a useful system to further address cell-fate decision pro-
cesses in lymphopoiesis.
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Introduction
 
Notch receptors and their ligands are phylogenetically
conserved transmembrane proteins which regulate cell-fate
decision processes during development and postnatal life
(1). In recent years, evidence has been accumulating
which demonstrates that Notch signaling plays a critical
role in the development of lymphoid B and T cell lineages
(2–3). Signaling through activated Notch has been impli-
cated in the decision processes underlying the functional
bifurcation of CD4/CD8 T lymphocytes (4), the choice
 
between 
 
  
 
 and 
 
  
 
 T cell receptors (5) and in maturation
 
processes of CD4
 
 
 
 and CD8
 
 
 
 cells; (6) though, more re-
cently, it has been shown that the absence of Notch-1 in
thymocytes at an early stage of development does not ap-
pear to disturb subsequent T cell maturation (7). On the
other hand, the constitutive activation of Notch-1 in
mouse bone marrow cells was shown to block B lym-
phopoiesis while promoting T cell differentiation within
the bone marrow (8). Conversely, transgenic mice with
inactive Notch-1 in bone marrow and thymus display a se-
vere impairment of T cell development while showing B
cell development within the thymus (9). These observa-
tions strongly suggest that Notch signaling may influence
the commitment of a common lymphoid progenitor (10)
towards differentiation into the B or T/natural killer
 
(NK)
 
*
 
 cell lineages. However, most of the above men-
tioned data reflect the effects of constitutively active forms
of Notch, not allowing the analysis of putative differential
actions induced by distinct Notch ligands. In mammalians
these include two protein families, the first corresponding
to homologues of 
 
Drosophila serrate
 
, Jagged-1 and -2 (11–
13), and the second to homologues of 
 
Drosophila delta
 
,
Delta-like-1, 3, and 4 (14–16). Jagged-1 and -2 are ex-
pressed in bone marrow and fetal liver stromal cells, in
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thymic epithelium and subsets of hematopoietic cells of
different lineages, suggesting that Notch activation may be
induced by interaction with these ligands in different he-
matopoietic environments (2). Several observations indi-
cate that Jagged-1 and -2 act by expanding and maintain-
ing primitive hematopoietic precursors while inhibiting or
delaying their terminal differentiation (17–21) though re-
cently, different views have emerged. Schroeder et al. (22)
reported that Jagged-1 accelerates granulocytic differentia-
tion of 32D cells, and the effects of Jagged-1 on prolifera-
tion and differentiation of human CD34
 
 
 
 
 
cells appear to
depend on the context of growth-promoting cytokines
(23). However, these experiments were conducted in con-
ditions that favor the differentiation into myeloid but not
lymphoid lineages, thus failing to reveal what kind of spe-
cific effects may be caused by Jagged-1 and -2 in the dif-
ferentiation processes of lymphoid cells. It is nonetheless
accepted that they might also act in lymphopoeisis, as
Jagged-1 and -2 are expressed in lymphoid tissues (2) and
mice without functional Jagged-2 have abnormal thymic
morphology and impaired differentiation of 
 
  
 
 T cells
(24). Accordingly, it has been recently shown that Jagged-1
is involved in the regulation of CD4:CD8 cell ratio during
thymic development (25).
Much less is known about the specific role of Delta
ligands. The Delta-1 gene is expressed in the corticomed-
ullary region of the newborn mouse thymus and in fetal
and adult human hematopoietic tissues (unpublished obser-
vations and reference 26). Moreover, a soluble form of hu-
man Delta-1 was shown to delay the acquisition of differ-
entiation markers by murine hematopoietic progenitors
and to promote the expansion of primitive precursors (26).
It would thus appear that different Notch ligands have re-
dundant actions at the level of early hematopoietic precur-
sors, promoting their expansion while preventing them to
pursue terminal differentiation. However, other observa-
tions indicate that this might not be the case. Notch ligands
have restricted patterns of expression during development
and in adult tissues and knockout mice for Notch-1 and -2,
Jagged-1 and -2, display distinct phenotypes (2). Therefore,
it is conceivable that the plurality of Notch receptors and
Notch ligands may translate into functional diversity of
Notch actions in vivo.
To address this issue, we asked, specifically, whether the
known inhibition of B cell development induced by active
Notch (8) could depend on the action of specific Notch
ligands. Making use of a cell coculture system previously
known to favor the selective differentiation of hematopoi-
etic progenitors into early B cells (27), we show that Delta-1
completely blocks the differentiation of progenitor cells
into the B cell lineage, while promoting the emergence of
a population of cells with characteristics of a T/NK cell
precursor. In contrast, Jagged-1 apparently did not disturb
the B or T/NK cell developmental potential of the original
cells. Taken together, our data show that Jagged-1 and
Delta-1 have differential effects in cell-fate decision pro-
cesses in human lymphopoiesis in vitro, strongly suggesting
that the interplay of Notch receptors with distinct ligands
 
may underlay diverse biological outcomes of Notch signal-
ing pathways.
 
Materials and Methods
 
Cord Blood CD34
 
 
 
 Cells.
 
Umbilical cord blood (CB) was
collected in sterile heparinized tubes according to the guidelines
approved by the Ethical Committee of the Lisbon Medical
School. Mononuclear cells were isolated by density gradient cen-
trifugation (Ficoll-Paque, Amersham Pharmacia Biotech) and
CD34
 
 
 
 cells subsequently obtained using the MiniMACS™ sepa-
ration column (Miltenyi Biotec). Technical procedures were done
accordingly to the instructions included in the CD34 Progenitor
Cell Isolation kit (QBEND/10). CD34
 
 
 
 expression on collected
cells varied from 80 to 95% as assessed by flow cytometry. Col-
lected cells were immediately processed for coculture experiments
or, alternatively, aliquoted and stored at 
 
 
 
80
 
 
 
C until use.
 
S17 Cell Line.
 
The murine stromal cell line S17 (provided by
D. Rawlings, UCLA, Los Angeles, CA) was used as a stromal cell
layer in coculture experiments with CB CD34
 
 
 
 cells exactly as de-
scribed by Rawlings and colleagues (27), without added cytokines.
 
Delta-1 and Jagged-1 cDNAs, Retroviral Vectors, and Producer Cell
Lines.
 
Full-length cDNAs encoding either the human Delta-1
or Jagged-1 (provided by G. Artavanis-Tsakonas, Harvard Medi-
cal School, Charlestown, MA) were cloned into the restriction
sites of BamHI and EcoRI of the LZRS-linker-IRES-enhanced
green fluorescent protein (eGFP) retrovirus (provided by H.
Spits, The Netherlands Cancer Institute, Amsterdam, Holland).
This vector permits the coexpression of cloned cDNAs and the
marker gene eGFP, from a single bicistronic message (28, 29).
The open reading frame of Delta-1 was PCR amplified, from a
plasmid containing the full length cDNA (GenBank accession
number AF003522), using Delta-1 specific primers also contain-
ing appropriate restriction sites. The upstream primer contains a
BamHI site: aa
 
GGATCC
 
accatgggcagtcggtgcgcgct. The down-
stream primer contains an EcoRI site: tt
 
GAATTC
 
ttacacctcagt-
tgctatgacgca (coding sequences are underlined, restriction sites are
given in bold). Restriction and sequence analysis were performed
to confirm proper amplification and ligation of the human Delta-1
open reading frame into the LZRS-polylinker-IRES-eGFP vec-
tor. High titres of empty (control GFP only) or recombinant vi-
rus were obtained after transfection of Phoenix-Ecotropic cell
line (provided by G. Nolan, Stanford University, Stanford, CA).
In brief, 2 d after transfection of the packaging cell line with a ret-
roviral construct, selection started by addition of 2 
 
 
 
g/ml of
puromycin (CLONTECH). 10–14 d after transfection, 15
 
   
 
10
 
6
 
puromycin selected cells were plated on T175 flasks (Becton
Dickinson) in 30 ml of medium without puromycin (29). The
following day the medium was replaced to remove dead cells and
24 h later retroviral supernatants were harvested, centrifuged, and
frozen in aliquots at –80ºC until further use. To test the efficiency
of the retroviral supernatants, NIH 3T3 cells were infected and
GFP production monitored by flow cytometry after 48 h of in-
fection (mean of 90% GFP
 
 
 
 cells).
 
Transduction of S17 Cells with Retroviruses Containing Delta-1 or
Jagged-1 cDNAs.
 
Aliquots of frozen retroviral supernatants con-
taining either Delta-1, Jagged-1, or the empty virus (control)
were thawed and incubated on ice after the addition of DOTAP
(DOTAP liposomal transfection reagent; Boehringer Mannheim)
at a final concentration of 100 
 
 
 
g/ml for 10 min. Subsequently,
pellets of 10
 
5
 
 of S17 cells were resuspended in the transfection
mixture and incubated for 6–18 h at 37
 
 
 
C, 5% CO
 
2
 
 in 1 well of a
24-well, flat-bottomed plate (Nunclon; Nalge Nunc Interna- 
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tional). The transfection mixture was then removed and the cells
transferred to a T25 flask (Falcon; Becton Dickinson) for further
culture in RPMI (Sigma-Aldrich), 10% FBS (GIBCO BRL), and
penicillin/streptomycin (p/s; GIBCO BRL). 48 h after transduc-
tion, S17 cells were analyzed for GFP expression by flow cytom-
etry. Transduced cells were subsequently sorted until 
 
 
 
90% of
the cells expressed GFP (see Fig. 1 a) and used for coculture ex-
periments with CB CD34
 
 
 
 cells.
 
Coculture Assays.
 
24 h before their use in coculture experi-
ments, 2
 
   
 
10
 
4
 
 S17 cells in 1 ml of medium were plated in 24-
well, flat-bottomed plates. Cocultures were initiated by seeding
5 
 
  
 
10
 
4
 
 CD34
 
 
 
 cells to the wells precoated with wild-type or
transduced S17 stroma, and the cultures were maintained at 37
 
 
 
C,
5% CO
 
2
 
. Half of the culture medium (RPMI, 10% FBS, p/s) was
replaced by fresh medium once a week. After the incubation pe-
riods (2, 4, and 6 wk), cells were harvested, counted, and used for
subsequent analyses and experimental assays.
 
Differentiation of NK Cells.
 
After a period of 3 wk of cocul-
ture on a monolayer of S17 stroma, supernatant cells were har-
vested, counted, and tested for their capacity to develop into NK
cells as described previously (30, 31). In brief, 1–2
 
   
 
10
 
4
 
 CB cells
were further cultured in U-bottomed, 96-well plates in the pres-
ence of 10 ng/ml Flt-3 ligand (R&D Systems), 10 ng/ml IL-7
(R&D Systems), and 10 ng/ml IL-15 (R&D Systems). Similar
cultures were started with fresh CB CD34
 
  
 
cells to control for
normal NK cell development in our system. The cultures were
maintained on a humidified atmosphere at 37
 
 
 
C in 5% CO
 
2
 
 for 3
wk. The cells were then stained with fluorochrome-labeled anti-
bodies (see below) and their antigenic phenotype analyzed by
flow cytometry.
 
Flow Cytometry and mAbs.
 
Flow cytometry analyses were
performed using a FACSCalibur™ (Becton Dickinson). Fresh
CB progenitors or supernatant cells harvested at different time
points, were stained with mAbs for 30 min, washed with a PBA
solution consisting of PBS supplemented with 2% BSA
(MERCK)
 
 
 
and 0.01% NaN
 
3
 
 (Sigma-Aldrich), and analyzed by
flow cytometry. For cytoplasmic staining of the CB cells, after
membrane staining, the cells were fixed in 1% paraformaldehyde
(Sigma-Aldrich) for 30 min. Next, the cells were washed with
PBA and permeabilized by incubation with a solution of 0.25%
saponin (Merck) for 2 min. The cells were washed again with
PBA and incubated for 30 min with the antibodies of interest for
detection of cytoplasmic expression. All steps of the staining pro-
cedure were carried out on ice and for both membrane and cyto-
plasmic staining, appropriate fluorochrome-conjugated, isotype-
matched control Igs were used in all experiments. The following
mouse anti–human mAbs (FITC-, PE-, PerCP-, or PE-Cy5 cou-
pled) were used: CD34-FITC, CD38-PE, CD34-PE, CD14-
FITC, and CD45-PE-Cy5 (purchased from CLB, Amsterdam,
The Netherlands), CD7-FITC, CD4-FITC, CD19-PE, CD33-
PE, CD56-PE, CD20-PE,
 
 
 
CD3-PerCP, CD34-PerCP, CD8-
PE, (all from Becton Dickinson), IgM-PE, and CD10-PE-Cy5
(BD PharMingen).
 
Functional Assays for Jagged-1 and Delta-1 Proteins.
 
The effi-
cacy of transduced Delta-1 and Jagged-1 proteins in the activation
of the Notch pathway was assessed in coculture experiments of
the myoblast cell line C2 (a gift from A. Israel, Unité de Biologie
Moléculaire de L’Expression Génique, Institut Pasteur, Paris,
France). The functionality of the constructs was initially verified
using NIH 3T3 cells transduced with either Jagged-1 or Delta-1
vectors cocultured with C2 cells as described by Jarriault and col-
laborators (32). As expected for a functional activation of Notch,
myoblast differentiation was inhibited in the presence of NIH
 
3T3 cells transduced with Jagged-1 or Delta-1, as assessed by
phase-contrast analysis and the expression of T-troponin (ob-
tained from the Developmental Studies Hybridoma Bank devel-
oped under the auspices of the NICHHD and maintained by the
University of Iowa, Department of Biological Sciences, Iowa
City, IA 52242) (immunocytochemical detection, data not
shown). To verify whether these proteins, when expressed by
S17 cells, maintained their functionality, similar experiments
were done using transduced S17 cells instead of NIH 3T3 cells.
As shown in Fig. 1 d a strong inhibition of myotube formation
was observed when C2 myoblasts were cocultured with trans-
duced S17 stromas for 4 d indicating that S17 cells are expressing
functional Jagged-1 and Delta-1 proteins.
 
Western Blot Analysis.
 
Wild-type and retrovirally transduced
S17 cells (with empty virus, Jagged-1 or Delta-1) were
trypsinized and washed in PBS before protein extraction. West-
ern blot analysis was done as described previously (33) using as
primary antibodies goat-anti–Delta-1 (Santa Cruz Biotechnology,
Inc.) and rat-anti–Jagged-1 (obtained from the Developmental
Studies Hybridoma Bank; Fig. 1 b). The FBMD-1 cell line (pro-
vided by R. Ploemacher, Department of Hematology, Erasmus
University, Rotterdam, Netherlands) transduced with the Jagged-1-
retrovirus and known to express the Jagged-1 protein was used as
a positive control for the anti–Jagged-1 antibody.
 
Real-Time PCR (TaqMan).
 
The expression of Notch-target
genes HES-1, Deltex, pre–T-
 
 
 
 and E47 was analyzed in CD34
 
 
 
cells cultured in the presence of Delta-1 or Jagged-1 for 48 h us-
ing quantitative RT-PCR. Total RNA was extracted from cell
pellets, lysed in GTC solution, and reverse transcribed using ran-
dom hexamer-primers (Amersham Pharmacia Biotech) as de-
scribed previously (34).
Primers and probes were designed using the Primer Express
software (Applied Biosystems). Expression of each target gene
was normalized using the endogenous gene hGAPDH (TaqMan
PDAR reagent; Applied Biosystems). Primers and probes of
genes under analysis were: HES-1 forward primer 5
 
 
 
 TGG AAA
TGA CAG TGA AGC ACC T 3
 
 
 
; HES-1 reverse primer 5
 
 
 
GTT CAT GCA CTC GCT GAA GC 3
 
 
 
; HES-1 probe CGC
AGA TGA CGG CTG CGC TG 3
 
 
 
 (GenBank accession num-
ber AF264785); E47 forward primer 5
 
  
 
AGA ACA CGT CAG
CGG CTG A 3
 
 
 
; E47 reverse primer 5
 
  
 
TAT TGG CCA TGC
GCC TCT 3
 
 
 
; E47 probe 5
 
  
 
TCC TCC AGG GAC AGC ACC
TCG C 3
 
 
 
 (GenBank accession number M65214); Deltex for-
ward primer 5
 
  
 
CAT CAT CGA CCT GCA GTC CA 3
 
 
 
; Del-
tex reverse primer 5
 
  
 
CGA CGA CGG GTC GTA GAA GT 3
 
 
 
;
Deltex probe 5
 
  
 
CAG GAC ACA GGC ACC ATG CGG 3
 
 
 
(GenBank accession number XM012258); pre-TCR-
 
 
 
 forward
primer 5
 
  
 
CAT CCT GGG AGC CTT TGG T 3
 
 
 
; pre-TCR-
 
 
 
reverse primer 5
 
  
 
CCG GTG TCC CCC TGA GA 3
 
 
 
; and pre-
TCR-
 
 
 
 probe 5
 
  
 
CCA TGC ATC TGT CAG GAG AGG CTT
CTA CAG 3
 
 
 
 (GenBank accession number U36759). Probes
were designed in exon/exon boundaries in order to avoid DNA
amplification and were labeled at the 5
 
  
 
end with the reporter dye
molecule FAM and at the 3
 
  
 
end with the quencher dye mole-
cule TAMRA. All transcripts were amplified in 25 
 
 
 
l reactions
using 2 
 
 
 
l of cDNA and the TaqMan Universal PCR Master
Mix (Applied Biosystems) according to the manufacturer’s in-
structions. Each reaction contained 300 nM of each primer and
200 nM of the labeled probe. Amplifications were done in an
ABI Prism 5,700 thermocycler (Applied Biosystems) for 2 min at
50
 
 
 
C, 10 min at 95
 
 
 
C, followed by 40 cycles of 15 s at 95
 
 
 
C, and
1 min at 60
 
 
 
C. The CEM cell line was used as standard. For the
GAPDH and each gene a logarithmic dilution of the CEM 
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cDNA was done to allow quantification. Expression values of the
wild-type samples at 48 h were used as calibrator. To analyze the
intra-assay variation, 10 replicates of a 10
 
 
 
1
 
 logarithmic dilution
of the CEM cDNA were studied for the endogenous control and
each one of the target genes. For each target gene the cycle
threshold values of the 10 replicates had SD values 
 
 
 
0.5. For
each experiment all triplicate values of samples and standards had
also SD of 
 
 
 
0.5 and the mean values of the triplicates were taken
as the final result.
 
Statistical Analysis.
 
Statistical analysis was performed using the
nonpaired Student’s 
 
t 
 
test.
 
Results
 
Delta-1 but not Jagged-1 Completely Inhibits the Differentiation
of CD34
 
 
 
 Hematopoietic Progenitors into the B Cell Lineage.
 
To investigate whether distinct Notch ligands have differ-
ent effects in human B cell differentiation, we have made
use of a cell coculture system with the murine stromal cell
line S17, which promotes the selective differentiation of
CB CD34
 
 
 
 cells into the B cell lineage (27). Expression of
Delta-1 or Jagged-1 in S17 cells was induced by transduc-
tion of retroviral vectors containing either human Jagged-1
or Delta-1 cDNAs. Protein expression was confirmed in
sorted transduced-S17 cells by immunoblotting (Fig. 1 a
and b) and immunocytochemical detection (data not
shown). To determine whether retroviral transduction per
se could affect the capacity of S17 cells to support B cell
differentiation, cells transduced with a vector containing
only IRES-eGFP sequences (vector alone) were cocultured
with CB CD34
 
 
 
 cells during 6 wk. No significant dif-
ferences were observed in the percentage of the CD19
 
 
 
CD10  cells emerging both in parental and transduced
stroma at three different time points, indicating that retro-
viral infection does not disturb the well documented (27)
capacity of these stromal cells to promote B cell differentia-
tion (Fig. 1 c). To confirm that the exogenous Jagged-1
and Delta-1 proteins expressed by S17 cells were capable of
activating Notch in Notch-expressing cells, parental and
transduced S17 cells were used as a support layer for the
differentiation of C2 myoblasts. We observed that both
Figure 1. Analysis of GFP and protein expression on transduced S17 cells, of B cell
differentiation in unmodified and vector-transduced S17 cells, and functional assays for
Jagged-1 and Delta-1 proteins. (a) Flow cytometric analysis of GFP expression 3 wk after
sorting for GFP  transduced S17 cells. Quadrants were set as to exclude GFP-negative
cells as determined by analysis of nontransduced cells. (b) Western blot analysis detection
of human Jagged-1 and Delta-1 proteins in S17 cells transduced with vectors containing
either Jagged-1 (S17 J1) or Delta-1 cDNAs (S17 D1) in the same samples as in a. FBMD
J1-FBMD1 cells transduced with vector containing human Jagged-1 cDNA. Molecular
weight markers are indicated on the right (kD). (c) Flow cytometric analysis of CD10
and CD19 expression in CD34  cells cocultured with parental S17 cells (S17 wt, top)
and S17 cells transduced with vector alone (S17 Vector, bottom) in three different time
points. (d) Delta-1 and Jagged-1 expressed by S17 cells inhibits the differentiation of C2
cells. Pictures were taken with the confocal microscope Zeiss LSM-510. C2, proliferat-
ing C2 cells; DM, differentiation medium (reference 11); S17 D1, S17 cells transduced
with Delta-1; S17 J1, S17 cells transduced with Jagged-1. Original magnification:  20.
(e) Expression levels of HES-1, Deltex, pre-T- , and E47 in CD34  cells cocultured with parental or transduced S17 cells for 48 h, as assessed by quan-
titative RT-PCR (n   2 for E47 and n   3 for other transcripts). Expression of each transcript was measured as a ratio with the GAPDH transcript and
expressed in arbitrary units (each transcript in CD34  cells cocultured with unmodified stroma   1).995 Jaleco et al.
Jagged-1 and Delta-1 transduced stromas strongly inhibited
the fusion of mononucleated myoblasts into multinucleated
myotubes (Fig. 1 d). This phenotype is identical to that ob-
served in the assays using transduced NIH 3T3 that were
initially performed to verify the functionality of retroviral
constructs (data not shown, see Materials and Methods),
and indicative of activation of the Notch pathway mediated
by both ligands (11, 32, 35, 36). Analysis of genes targeted
by Notch signaling (HES-1, Deltex, E47, and pre-T ) was
further done using quantitative RT-PCR. The study was
done in CD34  cells after 48 h of culture in the presence of
Notch ligands and control stroma. As shown in Fig. 1 e, a
marked increase in HES-1 expression was observed in
CD34  cells cultured in the presence of Delta-1, when
compared with control stromal conditions. In contrast,
lower levels of expression were observed for Deltex and
pre-T . E47 expression was half of that of control cultures
in the two samples analyzed for this gene. In Jagged-1 cul-
tures, a modest increase in HES-1 expression was observed
in contrast with E47 which was 5.2- and 2.9-fold in the
two samples analyzed for this gene. Deltex expression was
decreased whereas pre-T  expression was 1.6   0.6-fold
(Fig. 1 e).
CD34  cells were then cocultured with transduced stro-
mas for 6 wk. Parental or vector-alone-transduced S17 cells
were used as controls.
Supernatant cells collected at 2, 4, and 6 wk were
counted and analyzed for the expression of cell differentia-
tion antigens by flow cytometry. The increase in the total
number of cells cultured with control or Jagged-1 S17 cells
was similar at all time points, whereas the expansion of cells
cultured on Delta-1 stroma was significantly lower (P  
0.025) (mean values at 6 wk: eightfold in Delta-1 versus
17-fold in Jagged-1 and 20-fold in parental stromas).
The phenotypic analysis of supernatant cells (Table I)
showed an abrupt decrease in the percentage of CD34 
cells during the first 2 wk, and maintenance of CD38 at
levels similar to those observed in fresh CD34  cells, in all
experimental conditions. As to the myeloid markers CD33
and CD14, it was observed that the percentage of CD33 
Table I. CB CD34  Cells Cocultured with S17 Cells Transduced with Different Notch Ligands
Day 0 Week 2 (n   3) Week 4 (n   2–4)
n   4 WT Vector Jagged-1 Delta-1 WT Vector Jagged-1 Delta-1
CD34 87.1   6.4 11.4   5.4 16.6   5.0 13.5   6.5 18.6   10.5 3.8   3.3 2.6   1.7 5.5   3.1 5.0   3.2
CD38 97.1   0.8 96.5   2.7 94.6   3.8 94.6   3.8 97.3   3.9 98.3   2.0 93.9   3.1 95.3   3.6 95.9   1.6
CD10/CD19 1.9   1.4 21.0   5.7 10.1   3.9 21.7   15.6 0   0 66.8   18.1 58.8   15.7 55.5   12.3  0   0
CD33 77.9   10.4 25.2   3.6 24.4   3.1 25.1   9.1 10.4   3.8 18.4   10.6 17.4   5.9 22.5   4.5 7.4   2.0
CD14 1.4   1.0 13.7   5.9 16.4   1.4 9.7   6.9 5.7   1.9 17.2   13.5 10.7   4.3 16.3   3.1 4.2   1.3
CD7 10.1   2.7 ND ND ND ND 9.1   4.4 7.6 18.9   3.9 76.5   1.0
CD56 2.4   0.7  ND ND ND ND 1.5   0.5 3.8 2.2   0.7 6.0   1.2
CD4/CD8 0   0N DN D N D N D0     0 0 0   0 4.3   2.5
CD3 4.9   2.0 ND ND ND ND 1.5   0.6 1.0 3.3   1.4 3.6   1.3
Cyt CD3 ND ND ND ND ND ND ND ND ND
Week 6 (n   2–4) 
WT Vector Jagged-1 Delta-1
CD34 0.5   0.5 0 4.3   0.5 5.0
CD38 98.9   0.6 96.2 95.1   0.1 96.0
CD10/CD19 94.5   2.8 89.6 81.9   8.2 0   0
CD33 2.0   1.5 1.5 4.7   3.2 5.2   1.8
CD14 1.0   0.4 1.0 3.4   3.4 2.7   1.7
CD7 2.5   1.5 5.0 7.2   3.4 81.8   3.8
CD56 3.2   3.2 8.4 2.5 5.5   1.2
CD4/CD8 0   0 0 0 2.4   2.4
CD3 2.0   0.8 3.1 1.0 8.5   6.5
Cyt CD3 0   0 0 0   0 66.2   5.9
Expression of cell differentiation antigens (%   SE) on hematopoietic cells cocultured for 2, 4, and 6 wk with nontransduced and transduced S17
cells. Samples without SE, n   1. Delta-1, S17 cells transduced with Delta-1 cDNA; Jagged-1, S17 cells transduced with Jagged-1cDNA; ND, not
done. Vector, S17 cells transduced with vector alone; WT, parental S17 cell line.996 Delta-1 and Jagged-1 Genes in Lymphopoiesis
cells decreased progressively along the culture period, and
the expression of CD14, though having reached 30% at
week 4 for cells cultured in parental stroma, dropped to
 7% at week 6 in all stromas tested (Table I and Fig. 2).
The absence of myeloid differentiation in this culture sys-
tem is in agreement with previous findings using CB
CD34  cells cocultured with unmodified S17 cells (27). It
is, however, worth noting that the decrease in CD14 and
CD33 expression on cells cultured with Delta-1 stroma oc-
curred earlier than with the other stromas. These differ-
ences reached statistical significance at weeks 2 and 4 for
CD33 when compared with parental (week 2, P   0.005;
week 4, P   0.05) and Jagged-1 (week 2, P   0.05; week
4, P   0.005) stromas, and at week 4 for CD14 when
compared with Jagged-1 transduced stroma (P   0.0005)
(Table I).
As to the expression of the B cell markers CD10 and
CD19, a progressive increase in CD10 CD19  cells was
observed during the 6 wk culture of CB progenitors with
the control and Jagged-1 stromas. At week 6,  80% of all
cells coexpressed CD10 and CD19 (Table I), and ex-
pressed variable levels of CD20 although they were nega-
tive for IgM (data not shown). This phenotype is compati-
ble with cells at an early stage of B cell differentiation and
similar to what has been reported for cultures with un-
modified S17 cells (27). However, when CB progenitors
were cultured in the presence of Delta-1, no CD10 
CD19  cells could be detected at any time point (Table I
and Fig. 2), suggesting a strong inhibitory effect of Delta-1
on early B cell differentiation.
In summary, these data show that, in marked contrast
with Jagged-1, exposure of progenitor cells to Delta-1 in-
duces a severe block in B cell development. Additionally,
Jagged-1 and Delta-1 do not seem to impair the residual
myeloid differentiation observed in this in vitro system.
Coculture of CD34  Progenitors with Delta-1 Stroma Gives
Rise to a Population of Cells with Characteristics of T Cell/NK
Precursors. As shown above, the cell population emerging
in cultures with Delta-1–expressing stroma did not con-
tain any B cell precursors, nor did it possess features of
precursor cells differentiating along the myeloid lineage. A
small proportion of T cells (CD3 ) and NK cells (CD56 )
was found, also detectable in control and Jagged-1 stromas
(Table I), which might have resulted from the expansion
of contaminating mature cells present at the start of the
culture (Table I). The analysis of CD7 and cytoplasmic
CD3, two markers of T and NK cell precursors that ap-
pear before any other more mature antigens (37), showed
that  76% of the cells developing upon coculture with
Delta-1 stroma were CD7 ,  60% of which coexpressed
cytoplasmic CD3. This corresponds to an actual increase
in absolute numbers of these cells, when compared with
cultures in the other stromas (mean of 1.6   105 CD7 
cells in Delta-1 stroma versus 5   104 in Jagged-1 stroma).
Furthermore, examination of CD4 and CD8 expression in
cultures with Delta-1 transduced stroma revealed the pres-
ence of a de novo cell population, comprising between
2.4 and 6.8%, that coexpressed CD4 and CD8 (Tables I
and II). This was in marked contrast with the findings in
cultures with control (P    0.001) and Jagged-1 (P   
0.0025) stromas where only a minor proportion of cells
expressed CD7 at week 6, and no cytoplasmic CD3 or co-
expression of CD4 and CD8 was observed (Table I and
Fig. 3). Therefore, these observations imply that Notch
triggering by Delta-1, but not Jagged-1, induces the
emergence of two cell populations; a predominant one
bearing a phenotype of T and NK cell precursors and a
minor one, with a phenotype similar to that observed in
developing CD4  CD8  thymocytes.
CB CD34  Cells Cultured on Delta-1 Stroma Are Irrevers-
ibly Inhibited to Differentiate into B Cells but Can still Develop
into NK Cells upon Culture with IL-15, IL-7, and Flt-3
Ligand. Next, we tested whether the observed inhibition
of B cell differentiation by the Delta-1 stroma was an irre-
versible phenomenon. With this purpose, CB CD34 
cells were cocultured with Delta-1–expressing stroma for
3 wk, and then transferred to nontransduced stroma and
cultured for 3 more wk. No CD10 CD19  cells were de-
tected in these experimental conditions though, at the
time of transference, a proportion of cells (11% in the 2
samples analyzed) still exhibited an immature phenotype as
assessed by the expression of CD34 (data not shown).
Therefore, after 3-wk culture on Delta-1 stroma, CB cells
no longer retain the capacity to develop along the B cell
lineage. To exclude the possibility that this was due to a
general impairment of the progenitor cells to differentiate
Figure 2. Phenotypic analysis of hematopoietic cell populations found
after 6 wk of coculture of CD34  cells with parental and transduced S17
stroma. Supernatant cells were counter-stained with anti-CD10/anti-
CD19 for detection of pre-B cells (left) and with anti-CD14/anti-CD33
for detection of myeloid precursors (right). For the sake of simplicity,
since results obtained with vector alone–transduced S17 cells were identi-
cal to those observed with parental stroma (see Table I), only the latter
are depicted.997 Jaleco et al.
into any cell type, cells cocultured with Delta-1–express-
ing stroma for 3 wk were transferred to a cell suspension
system and cultured for 3 more wk in the presence of IL-
15, IL-7, and Flt-3L. This cytokine cocktail is known to
favor the differentiation of hematopoietic precursors into
the NK cell lineage (31). We found that those cells could
develop into CD56  cells, acquiring a phenotype similar
to that observed for fresh CB CD34  cells cultured for 3
wk in suspension with the same cytokines (Table II and
Fig. 4). A similar behavior was observed for cells cultured
on parental and Jagged-1 stromas (Table II), indicating
that neither Jagged-1 nor Delta-1 disturbed the capacity of
this cytokine combination to either promote differentia-
tion of precommitted NK-cell precursors or expand pre-
existent NK cells.
Discussion
In this report we show that two distinct human Notch
ligands, Delta-1 and Jagged-1, have differential effects in
human lymphoid differentiation. In a culture system spe-
cially suited for the differentiation of hematopoietic pro-
genitors into early B cells, Delta-1 signaling induces a com-
plete and persistent block of B cell differentiation, while
allowing the emergence of a cell population with a pheno-
type of T/NK cell progenitors. In contrast, Jagged-1 did
not apparently interfere with the lymphoid developmental
potential of hematopoietic progenitors.
These findings highlight a fundamental difference be-
tween the actions of two distinct Notch ligands, though
constitutive Notch activation in mouse bone marrow cells
has been previously shown to induce a persistent block of
Table II. CB CD34  Cells Cultureda with IL-15/IL-7/Flt-3L
Sample Antigens Day 0 3w IL-15b 3w Stroma 3w Stroma   3w IL-15b
WT Jagged-1 Delta-1 WT Jagged-1 Delta-1
1 CD7 10.5 88.2 22.6 19.1 67.5 27.8 39.5 82.4
CD56 1.7 69.1 1.3 2.0 3.4 56.6 59.8 77.2
CD4/CD3 1.9 24.0 0.5 0.5 1.0 9.9 10.3 10.9
CD8/CD3 1.2 8.2 0 0.5 0.5 3.5 4.7 4.2
CD4/CD8 0 2.5 0 0 0.5 1.4 1.1 4.0
2 CD7 15.1 90.3 13.4 15.3 77.5 28.4 54.7 73.6
CD56 4.5 55.5 1.0 1.9 7.0 32.4 53.1 62.9
CD4/CD3 5.5 14.1 1.4 3.4 14.3 3.7 13.1 14.5
CD8/CD3 2.5 7.2 0.6 1.2 7.2 2.2 9.7 3.5
CD4/CD8 0 1.7 0 0 3.0 0 0 2.8
Data represent percentages of positive cells for expression of the indicated T and NK cell markers. Cellular expansion was identical for cultures with
IL-15 but considerably lower for cultures with Delta-1 stroma as discussed in the Results. WT, parental S17 cell line; Jagged-1; S17 cells transduced
with Jagged-1 cDNA; Delta-1, S17 cells transduced with Delta-1 cDNA.
aCulture in suspension for 3 wk.
bIL-15 + IL-7 + Flt-3L.
Figure 3. Expression of surface CD7 and cytoplasmic CD3 on progen-
itor cells cocultured with S17 cells. CB cells were cultured for 6 wk on
parental (left), Jagged-1-transduced (middle), or Delta-1–transduced
(right) stroma, and analyzed for expression of surface CD7 and cytoplas-
mic CD3. Histograms of cells stained with the indicated mAbs are de-
picted in black and cells stained with isotype-matched mouse IgG are de-
picted in white. Results are representative of two different experiments.998 Delta-1 and Jagged-1 Genes in Lymphopoiesis
B cell maturation and the ectopic appearance of early T
cells in the bone marrow environment (8). Therefore, the
novel observation in the present work is that, in a ligand-
dependent context, those effects appear to be ligand-type
specific, rather than a common endpoint of Notch trigger-
ing by different ligands.
In our study, the block of B cell differentiation in cul-
tures with Delta-1–expressing stromas was evident as early
as the second week of culture, and seemingly an irrevers-
ible phenomenon, as immature supernatant cells when
transferred from transduced to non-modified stroma failed
to develop into CD19 CD10  cells. The predominant cell
population emerging in Delta-1–expressing stromas was
characterized by the expression of CD7 and cytoplasmic
CD3, features compatible with those of T/NK cell progen-
itors (37). This population remained phenotypically stable
between the fourth and sixth wk of culture, and registered
a moderate growth in the same period, suggesting that
Delta-1, though possibly having an active role in the gen-
eration and maintenance of these cells, does not behave as a
strong mitogenic factor. Importantly, the absolute numbers
of CD7-expressing cells were significantly higher in Delta-1
cultures, when compared with those with other stromas.
This indicates that Delta-1 induces a preferential expansion
of CD7  cells in this experimental system. Furthermore,
when these cells were transferred to medium containing
IL-15, IL-7, and Flt-3L, it became clear that rather than
being frozen in that particular stage of differentiation they
were capable of developing at least towards the NK cell
lineage. This is in agreement with the observation that
constitutive Notch activation in hematopoietic precursors
establishes immortalized cell lines which are still capable of
cytokine-dependent differentiation into lymphoid or my-
eloid cell lineages (38).
In contrast with Delta-1, Jagged-1–expressing stromas
consistently gave rise to cells with an early B cell pheno-
type, similar to those observed in cultures with control
stromas. Acquisition of CD56 was also observed when su-
pernatant cells previously grown with Jagged-1 stroma
were transferred to IL-15–containing medium. Thus,
Jagged-1 does not appear to significantly disturb neither B
cell nor NK potential of CD34  progenitor cells. Jagged-1
is known to  promote the survival of primitive fetal and
bone marrow precursors (18, 23) and to behave as a growth
factor of human hematopoietic stem cells (39). The present
data suggest that Jagged-1 also allows the survival and ex-
pansion of both early B and early T/NK cell progenitors in
vitro. As Jagged-1 is expressed in bone marrow and thymic
stromas (for a review, see references 2 and 40) a possibility
is that Jagged-1 might contribute to the survival of devel-
oping cells belonging to different hematopoietic lineages in
distinct environmental niches.
As to the biological mechanisms that may underlay the
differential effects of Delta-1 and Jagged-1 on B cell devel-
opment observed in this study, at least two (nonmutually
exclusive) possibilities can be envisaged. One is that the ob-
served absence of B cells in cultures with Delta-1–express-
ing stromas might partly be due to specific apoptosis of B
cell progenitors. Supporting this idea is the recent finding
that constitutive activation of Notch-1 induces cell-cycle
arrest and apoptotic cell death in a chicken B cell line (41).
Furthermore, a specific role for Delta-1 in apoptosis has
been previously proposed in studies where Delta-1 was
shown to induce apoptosis in monocytic cells (42). This ef-
fect could additionally explain our observation that CD33 
myeloid progenitors disappear faster in Delta-1 cultures
when compared with other cultures. It is also known that
Notch activation provides antiapoptotic signals in develop-
ing T cells (3). It thus appears that Notch signaling is capa-
ble of differentially regulating cell death in B and T lym-
phoid cell lineages. If so, the present data would further
suggest that such differential effects might depend on
Notch-triggering by distinct ligands, Delta-1 possibly me-
diating apoptosis in B cells only. Apart from a putative ef-
fect on cell apoptosis, another possibility is that Notch-trig-
gering by Delta-1 (but not by Jagged-1) might deliver a B
cell differentiation inhibitory signal to a common lymphoid
precursor which would then choose the alternative T/NK-
Figure 4. Differentiation capacity of CB progenitors into the B and
NK cell lineages after 3 wk coculture with Delta-1–transduced S17 cells.
Supernatant cells harvested after 3 wk culture on Delta-1 stroma were
transferred to either parental stroma (wt) to test for their B cell differenti-
ation potential, or to a cytokine cocktail consisting of IL-15, IL-7, and
Flt-3L (IL-15) to test for their capacity to differentiate into NK cells.
(Bottom) Expression of NK cell markers in CD34  CB cells cultured for
3 wk in suspension with IL-15, IL-7, and Flt-3L.999 Jaleco et al.
cell fate. Two candidate downstream targets of Notch acti-
vation have been convincingly implicated in the regulation
of B and T cell development (for a review, see reference
43): HES-1, which is upregulated in cells undergoing T
cell lineage specification and is required for the develop-
ment of normal T cell numbers; and E47, a product of the
E2A gene, which is essential for B cell specification. Since
Notch signaling was shown to inhibit E47 activity (44), and
mice lacking E2A display a complete block of B cell differ-
entiation (45), it is possible that the inhibition of B cell de-
velopment observed in this study might be caused by
Delta-1–mediated repression of E47. It is in this respect
noteworthy that, as opposed to Jagged-1, which is present
in bone marrow and thymic stroma (2, 40), Delta-1 appears
to be expressed at low levels (19, 46) or not at all (40) by
bone marrow stromal cells, though it is detected in murine
thymus (reference 26 and unpublished results). On the
other hand, Delta-1 activation of Notch signaling is known
to result in HES-1 transactivation (32), an effect that could
explain the accumulation of cells with a phenotype of
T/NK progenitors in Delta-1–expressing stromas as described
in this paper. Our results on the expression of Notch target
genes appear to support this idea. The expression of HES-1
in CD34  cells cultured in the presence of Delta-1, when
compared with cells cultured with unmodified stroma, is
markedly upregulated in contrast with E47 (which was 0.5-
fold in the two samples analyzed). It is conceivable that E47
might be functionally repressed by HES-1 in these cells as it
is known that this protein associates with E47 inhibiting its
DNA-binding activity (47). In contrast, the expression of
Deltex, other known inhibitor of E47 was virtually un-
changed in Delta-1 cultures. A different pattern was ob-
served in CD34  cells cultured in the presence of Jagged-1
where HES-1 expression was only modestly increased. In-
terestingly, our results on HES-1 expression in Jagged-1
cultures are reminiscent of those of Shawber et al. (35) and
Nofziger et al. (36) in their studies on the role of Notch in
muscle cell differentiation. These authors observed that
Jagged-1, despite inhibiting myogenesis (as observed in this
study), did not upregulate HES-1 expression in myoblast
precursor cells (35). Furthermore, evidence was provided
for the existence of a CBF-1 independent (and yet un-
known) Notch signaling pathway induced by Jagged 1
(36). Thus, it is possible that Jagged-1 might also act
through a CBF-1 independent pathway in hematopoietic
cells. An increased expression of E47 accompanied by a de-
crease in the expression of Deltex was observed in Jagged-1
cultures what is in agreement with the development of
early B cells in these conditions. As to the expression of
pre-T , although it has been reported that T cell lines (6)
and bone marrow precursor cells (48) transduced with
Notch IC upregulate its expression, we observed that tran-
scripts of this gene were either unchanged or slightly in-
creased both in Jagged-1 and Delta-1 cultures. As these re-
sults were obtained in a short time culture assay (when
CD34  cells have not yet acquired any T cell marker), a
possibility is that upregulation of pre-T  expression may
occur at later time points of culture, when cells have
reached a more advanced developmental stage. Studies
aimed at clarifying this issue are now under way.
In conclusion, our results show that the differential ef-
fects of Notch signaling during B and T cell development
may be mediated by distinct Notch ligands and introduce a
novel in vitro system with which cell-fate decision phe-
nomena in lymphopoiesis can be further addressed.
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